On the other hand, we found a robust association between elevated chemerin and increased beta-cell function which points towards a novel beneficial role of chemerin for dynamic insulin secretion in the context of NAFLD and type 2 diabetes. This evidence concerns the gene RARRES2 and metabolic dysfunction-associated steatotic liver disease.